Equity research

The question a desk answers well here is narrow and answerable: what did this company file, over which periods, and what do the numbers say once they are put side by side. The question it refuses is the one that sounds similar — whether the share is worth buying.

#What the desk does

1. Resolve the company into a listed instrument first. The tool returns candidates, never a verdict: an ordinary share, a preference share and a depositary receipt are not the same investment, and the choice is left to you.
2. Read the filings where the company actually files — the US regulator for a domestic or New York listing, the European mechanisms for a European one. Called without a concept, the tool returns what that issuer actually tags, which is where a reading starts.
3. Pull the price series and the option chain when the question needs them, each with the provenance it returns.
4. Open a chart module so you see the same data the mandate reasoned over.
5. Compose the dossier: facts with their sources, assumptions with their rationale, computations in the bounded language.

#Which mandates are involved

The fundamental mandate holds filings, market data and instrument resolution — and no web access, so it cannot substitute a commentary for a filing. The accounting mandate owns the workbook. The risk mandate can veto an adoption. The host routes; it never runs the analysis.

#What comes back, and what does not

• VERIFIEDA chart module on the canvas, from a real seriesObserved in live runs, and the screen captures on this site are sealed against a named build — the capture carries its version, taken on 2026-09-08.
• AVAILABLEA traced answer with its sourcesEvery tool that reports a source writes it to the journal with its address, period, metric, unit and read date. A figure without provenance does not ship.
• AVAILABLEA workbook, a deck and a memo from one dossierThe three engines are compiled into the build and covered by tests. No agent has produced them in a real run yet.
• PLANNEDA recommendation to buy or sellNever. The output of a mandate is an argued thesis, not an order addressed to you — a regulatory constraint written into the product, not a limitation of this release.